Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03449511 · ClinicalTrials.gov registry record · NA
Aromatherapy for Integrated Cancer Care
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT03449511 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 83 participants.
The verdict
NCT03449511, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to determine the feasibility and effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy. Aromatherapy is a noninvasive, minimal risk intervention that could potentially alleviate the severity of treatment-related symptoms. This study will evaluate the ability of four aromatherapy scents (ginger, lavender, orange, jojoba) to reduce the severity of seven chemotherapy-induced symptoms (nausea, vomiting, pain, anxiety/distress, fatigue, sleep difficulties, and lack of appetite). Jojoba oil is a " carrier oil" and will act as a placebo comparator in this study. Jojoba oil is present in small amount (1 drop) in the ginger, lavender, and orange aromatherapy inhalers. As part of the study, the participants will be asked to use an aromatherapy inhaler, which resembles a lipstick container, during three chemotherapy cycles. The participants will use the aromatherapy inhaler for 7 consecutive days. The investigators will ask the participants questions regarding demographics, clinical information, current severity of symptoms, and current methods of symptom management. There is a non-intervention baseline cycle during which subjects rate the severity of the seven different symptoms from 0 to 10 for seven consecutive days during their first chemotherapy study cycle. The next two study cycles are intervention cycles using the randomized aromatherapy. The participants will rate the severity of seven different symptoms from 0 to 10 each day the aromatherapy inhaler during one or two chemotherapy cycles (i.e., 7 consecutive days during each chemotherapy cycle). At the end of the study, the participants will be asked about his/her satisfaction with the aromatherapy used during the study. All of these measurements will provide a better understanding of the effectiveness of aromatherapy for symptom management.
Interventions
- OTHER Ginger aromatherapy
- OTHER Orange aromatherapy
- OTHER Lavender aromatherapy
- OTHER Jojoba aromatherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2018-04-11 |
| Est. Completion | 2023-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03449511
The ClinicalTrials.gov registry entry for NCT03449511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ginger aromatherapy is the first listed.
NCT03449511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03449511 about?
NCT03449511 is a clinical study titled "Aromatherapy for Integrated Cancer Care". The purpose of this clinical trial is to determine the feasibility and effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy. Aromatherapy is a noninvasive, minimal risk intervention that could potentially alleviate the severity of treatment...
What is the current status of trial NCT03449511?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2018-04-11. Estimated completion is 2023-01-30.
What interventions are being tested in trial NCT03449511?
The interventions under investigation include: Ginger aromatherapy (OTHER), Orange aromatherapy (OTHER), Lavender aromatherapy (OTHER), Jojoba aromatherapy (OTHER).
Who is sponsoring clinical trial NCT03449511?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.